Reverse transcription–PCR analysis demonstrated the presence of CYP3A4 mRNA in 15% (Huang et al, 1996) and 75% (Hellmold et al, 1998) of tested breast cancer samples, respectively. The gene discussed is CYP3A4; the disease is breast carcinoma.